9/29/2011 ScinoPharm Taiwan, Ltd. Begins New Era as a Publicly Traded Company ScinoPharm Taiwan, Ltd. (TWSE1789) a leading global supplier of active pharmaceutical ingredients (APIs), announced that it will begin trading its shares today on the Taiwan Stock Exchange Board.
